Danny Mancheno

Statistics

Publications

Citations

448

H-Index

Active since

2000

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Emory University

MSD (UK) Limited (United Kingdom)

Danny Mancheno is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in chemistry, natural sciences, and synthetic medicinal chemistry.

Publications per year

2000–2012

Publications

Detection of “oncometabolite” 2-hydroxyglutarate by magnetic resonance analysis as a biomarker of IDH1/2 mutations in glioma

Juliya Kalinina, Anne Carroll, Liya Wang et al. · Journal of Molecular Medicine · 2012 · 82 citations

Medicine, Biochemistry, Oncology +14

Copper-Catalyzed Olefin Aminoacetoxylation

Danny Mancheno, Aaron R. Thornton, Armin H. Stoll et al. · Organic Letters · 2010 · 82 citations

Natural Sciences, Chemistry, Catalysis +9

Diastereoselective Friedel−Crafts Alkylation of Indoles with Chiral α-Phenyl Benzylic Cations. Asymmetric Synthesis of <i>Anti</i>-1,1,2-Triarylalkanes

John Y. L. Chung, Danny Mancheno, Peter G. Dormer et al. · Organic Letters · 2008 · 67 citations

Natural Sciences, Chemistry, Catalysis +13

Polycations. Part X. LIPs, a new category of room temperature ionic liquid based on polyammonium salts

Sharon I. Lall, Danny Mancheno, Steve Castro et al. · Chemical Communications · 2000 · 65 citations

Natural Sciences, Chemistry, Materials Science +16

Development of a Second-Generation, Highly Efficient Manufacturing Route for the HIV Integrase Inhibitor Raltegravir Potassium

Guy R. Humphrey, Philip J. Pye, Yong‐Li Zhong et al. · Organic Process Research & Development · 2010 · 50 citations

Pharmacy, Chemistry, Medicinal Chemistry +17

1–5 of 9